Update on Early Combination Therapy with Lastest Monoclonal Antibodies and Antivirals as HIV, HCV, Influenza in Extremely Vulnerable Persons with Sars-Cov-2: A Literature Review and Clinical Experience
Journal Title: Journal of Clinical Medical Research - Year 2025, Vol 6, Issue 1
Abstract
The emergence of new variants of concern in immunocompromised persons with SARS-CoV-2, particularly those with mutations in the spike protein, has complicated treatment strategies. Some Therapies focused only on viral clearance effects and not on major clinical outcomes. As the virus continues to evolve, the development of broad-spectrum therapies, along with personalized approaches to treatment, will be crucial in managing COVID-19 . After the first year period in which several treatments were employed early intervention strategies, including the use of antiretrovirals and monoclonal antibodies, have emerged as promising approaches to mitigate the severity of COVID-19 in fragile individuals and prevent disease progression, hospitalization and death even in recent time with less aggressive SARS-CoV-2 variants. Guidelines, high-quality data for combination treatment exploiting antivirals and neutralizing antibodies do not exist in the outpatient setting, especially in severe immunocompromised individuals. Nevertheless, several studies have attempted to investigate the efect of this approach and although these are often observational studies without control groups, generally no severe adverse reactions from the combination therapy have been reported. The potential efficacy of early combination therapy, based on an antiviral plus a monoclonal antibody, for COVID-19 in severely immunocompromised patients is matter of clinical and literature debate in the scientific word. To date, information concerning the early treatments of COVID-19 using combined therapies has been limited. In this Literature Review we explain the Last variant of concern and the updates on combination therapy for vulnerable persons with Sars-Cov-2.
Authors and Affiliations
Weimer LE1*, Cattari G2, Fanales Belasio E3, Cuccuru E2, Vidili G2
Keywords
Related Articles
- EP ID EP758354
- DOI https://doi.org/10.46889/JCMR.2025.6102
- Views 34
- Downloads 0
Current Review: Hyperbaric Oxygen Analysis with Appropriate Cognitive Assessment
Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves placing a patient in a pressurised chamber and administering 100% oxygen. Recently, there has been growing interest in the cognitive benefits of HBOT,...
ChatGPT/AI in Healthcare Management
ChatGPT is forging a revolution in the realm of human-computer interaction, establishing new paradigms for what artificial intelligence can achieve. Also known as the Generative Pretrained Transformer (GPT), ChatGPT repr...
Innovative Nutraceutical Effectively Manages Canine Atopy
Like people, dogs may be allergic to numerous substances that their bodies touch or are found in the air or in food. These allergens enter the body by inhalation, direct contact or absorption, i.e., through the skin or r...
Essential Newborn Care Practice and Associated Factors among Home Delivered Mothers within the Past Six Months, in Abaya District, West Guji zone, Oromia Regional State, Ethiopia, 2019
Background: Poor immediate new-born care practice increases risk of morbidity and mortality by predisposing the new-borns to sepsis and hypothermia. In developing countries nearly 3 million new-borns babies die every y...
Assessment of Renal Function Tests and Serum Total Protein among Pregnant Women with Pregnancy-Induced Hypertension Attending in Asrade Zewudie Memorable Hospital (ASZMPH), Gojjam, Ethiopia: Case-Control Study
Background: Pregnancy-induced hypertension has remained a significant global public health threat in both developed and developing countries. Therefore, this study aimed to assess renal function tests and serum total p...